MAGE-3.A1 peptide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MAGE-3.A1 peptide, covering 2021-07-21 to 2021-07-21. Get the full timeline:
Most recent: Clinical Trial Update: Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma [Phase 1, Phase 2]